Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Cross Infection

moxifloxacin has been researched along with Cross Infection in 30 studies

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's20 (66.67)29.6817
2010's8 (26.67)24.3611
2020's2 (6.67)2.80

Authors

AuthorsStudies
Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A1
Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC1
Karlowsky, JA; Laing, NM; Zhanel, GG1
Appelbaum, PC; Bhagwat, SS; Kosowska-Shick, K; McGhee, P; Patel, MV1
Abdrabou, AMM; Berger, FK; Bischoff, M; Gärtner, BC; Margardt, L; Mellmann, A; von Müller, L1
Balejova, M; Capek, V; Cermak, P; Curdova, M; Drevinek, P; Geigerova, L; Havlinova, L; Jezek, P; Krutova, M; Kucharova, A; Nemcova, D; Nyc, O; Nycova, E; Ryskova, L; Tejkalova, R; Vagnerova, I; Vesela, D; Vojackova, S; Zamazalova, D1
Cheng, A; Chuang, YC; Sheng, WH; Wang, JT; Yang, JJ1
Balassiano, IT; Boente, RF; Brazier, J; Domingues, RM; dos Santos-Filho, J; Hall, V; Lobo, LA; Miranda, KR; Nouér, SA; Secco, DA1
Cai, X; Cui, J; Ni, W; Wei, C1
Chang, SH; Chien, HI; Chien, ST; Hsu, CH; Hsueh, JC; Lee, PL; Lee, TM; Yang, MC; Yang, TF1
del Mar Gamboa-Coronado, M; López-Ureña, D; Montoya-Ramírez, M; Quesada-Gómez, C; Rodríguez, C; Rodríguez-Cavallini, E; Somogyi, T1
Barbanti, F; Spigaglia, P1
Bachinskaia, EN; Beloborodova, NV; Kuznetsova, ST; Popov, DA; Vostrikova, TIu1
Burkhardt, O; Welte, T1
Hsueh, PR; Huang, YT; Liao, CH; Liu, CY; Lu, CL1
Carman, RJ; Genheimer, CW; Hiltonsmith, MF; Lyerly, DM; Park, M; Rafii, F1
Donskey, CJ; Ellis-Reid, T; Gerding, DN; Jump, RL; Pultz, MJ; Riebel, W; Riggs, MM; Salata, RA; Sethi, AK1
Ackermann, G; Christner, M; Ilchmann, C; Rohde, H; Speicher, A; Zaiss, NH1
Spence, RP; Towner, KJ1
Karpov, OI; Strekachev, AIu; Zaĭtsev, AA1
Andremont, A; Cavallo, P; Chardon, H; Courvalin, P; Dabernat, H; Drugeon, H; Etienne, J; Goldstein, F; Leclercq, R; Nguyen, J; Rio, Y; Soussy, CJ1
Ahmad, RN; Butt, T; Usman, M1
Choudhri, S; Herrington, J; Malangoni, MA; Pertel, P; Song, J1
Rodríguez, JC; Royo, G; Ruiz, M; Sirvent, E1
Biller, P; Brennan, M; Killgore, G; Lind, L; McDonald, LC; Shank, B; Thompson, A; Tkatch, L1
Barth, J; Beckmann, H; Höffken, G; Rubinstein, E1
Ruef, C1
Davydow, DS; Reti, IM1
Citron, DM; Goldstein, EJC; Rybak, MJ; Tyrrell, KL; Warren, YA1
Gottlieb, T; Leroi, MJ; Siarakas, S1

Reviews

2 review(s) available for moxifloxacin and Cross Infection

ArticleYear
10 years' experience with the pneumococcal quinolone moxifloxacin.
    Expert review of anti-infective therapy, 2009, Volume: 7, Issue:6

    Topics: Anti-Bacterial Agents; Aza Compounds; Cross Infection; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors; Treatment Outcome

2009
[New approaches to antibacterial therapy of infections in the surgical practice].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:5

    Topics: Abdominal Abscess; Aza Compounds; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Cross Infection; Ertapenem; Fluoroquinolones; Humans; Lactams; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic; Surgical Wound Infection

2003

Trials

2 trial(s) available for moxifloxacin and Cross Infection

ArticleYear
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.
    Annals of surgery, 2006, Volume: 244, Issue:2

    Topics: Abdominal Abscess; Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendicitis; Aza Compounds; Bacterial Infections; Cross Infection; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Intestinal Perforation; Male; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Quinolines; Safety; Stomach Rupture; Treatment Outcome

2006
A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia.
    Infection, 2007, Volume: 35, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteria; Ceftriaxone; Cefuroxime; Cross Infection; Drug Therapy, Combination; Endpoint Determination; Female; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Treatment Outcome

2007

Other Studies

26 other study(ies) available for moxifloxacin and Cross Infection

ArticleYear
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid

2007
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan

2008
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests

2008
In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin Resistance

2009
Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019-2021.
    Anaerobe, 2022, Volume: 77

    Topics: Anti-Bacterial Agents; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Ribotyping; Rifampin; Sentinel Surveillance

2022
The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients.
    Antimicrobial resistance and infection control, 2020, 06-30, Volume: 9, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Czech Republic; Feces; Female; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Ribotyping

2020
Impact of broad-spectrum antimicrobial treatment on the ecology of intestinal flora.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:5

    Topics: Acinetobacter baumannii; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Feces; Female; Fluoroquinolones; Gastrointestinal Microbiome; Humans; Male; Microbial Viability; Middle Aged; Moxifloxacin; Pseudomonas aeruginosa; Taiwan

2018
Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain.
    Anaerobe, 2014, Volume: 28

    Topics: Adult; Anti-Bacterial Agents; Bacterial Toxins; Brazil; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Resistance, Bacterial; Enzyme-Linked Immunosorbent Assay; Feces; Female; Fluoroquinolones; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Moxifloxacin; Ribotyping

2014
A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
    Infectious diseases (London, England), 2015, Volume: 47, Issue:12

    Topics: Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cross Infection; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Minocycline; Monte Carlo Method; Moxifloxacin; Pneumonia; Sputum; Stenotrophomonas maltophilia; Tigecycline

2015
Molecular Characterization of Community- and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Isolates in Southern Taiwan.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Moxifloxacin; Staphylococcal Infections; Taiwan

2015
Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
    Emerging microbes & infections, 2016, May-11, Volume: 5

    Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Communicable Diseases, Emerging; Costa Rica; Cross Infection; Diarrhea; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genes, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Ribotyping; Time Factors; Vancomycin

2016
Characterization of Clostridium difficile PCR-ribotype 018: A problematic emerging type.
    Anaerobe, 2016, Volume: 42

    Topics: Anti-Bacterial Agents; Antibiosis; Bacterial Adhesion; Bacterial Toxins; Caco-2 Cells; Clindamycin; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Erythromycin; Fluoroquinolones; Hospitals; Humans; Italy; Moxifloxacin; Ribotyping; Rifampin; Virulence

2016
[New indications for novel fluoroquinolones: moxifloxacin in the treatment of nosocomial infections].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2009, Volume: 54, Issue:1-2

    Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Male; Methicillin Resistance; Middle Aged; Moxifloxacin; Postoperative Complications; Quinolines; Treatment Outcome

2009
In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2009, Volume: 28, Issue:12

    Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Community-Acquired Infections; Cross Infection; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Peritonitis; Quinolines; Taiwan; Tigecycline

2009
Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea.
    Anaerobe, 2009, Volume: 15, Issue:6

    Topics: Anti-Bacterial Agents; Aza Compounds; Clostridioides difficile; Cross Infection; Diarrhea; Disease Outbreaks; DNA Gyrase; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genetic Variation; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Polymerase Chain Reaction; Quinolines; Ribotyping

2009
Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USA.
    Emerging infectious diseases, 2010, Volume: 16, Issue:5

    Topics: Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Feces; Fluoroquinolones; Gatifloxacin; Genes, Bacterial; Hospitals; Humans; Moxifloxacin; Ohio; Quinolines

2010
Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:12

    Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Bacterial Typing Techniques; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Erythromycin; Fluoroquinolones; Germany; Hospitals, University; Humans; Microbial Sensitivity Tests; Moxifloxacin; Polymerase Chain Reaction; Prevalence; Quinolines; Ribotyping

2010
Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of Acinetobacter baumannii.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aza Compounds; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines

2003
In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:10

    Topics: Anti-Infective Agents; Aza Compounds; Cross Infection; Fluoroquinolones; France; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines

2003
Potential role of moxifloxacin in methicillin-resistant Staphylococcus aureus (MRSA) infections.
    JPMA. The Journal of the Pakistan Medical Association, 2004, Volume: 54, Issue:1

    Topics: Aza Compounds; Cross Infection; Fluoroquinolones; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus aureus

2004
[Study investigating the activity of several fluoroquinolones against Pseudomonas aeruginosa using the mutant prevention concentration].
    Enfermedades infecciosas y microbiologia clinica, 2006, Volume: 24, Issue:10

    Topics: Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Genes, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutagenicity Tests; Mutation; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines

2006
Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain.
    Infection control and hospital epidemiology, 2007, Volume: 28, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Quinolines; Risk Factors

2007
Nosocomial pneumonia - are economical considerations important?
    Infection, 2007, Volume: 35, Issue:6

    Topics: Administration, Oral; Aza Compounds; Ceftriaxone; Cefuroxime; Cross Infection; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia; Quinolines

2007
Electroconvulsive therapy and antibiotics: a case report.
    The journal of ECT, 2007, Volume: 23, Issue:4

    Topics: Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Cross Infection; Depressive Disorder, Major; Electroconvulsive Therapy; Electroencephalography; Female; Fluoroquinolones; Humans; Moxifloxacin; Quinolines; Recurrence; Respiratory Tract Infections; Retreatment

2007
Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus.
    Journal of medical microbiology, 2008, Volume: 57, Issue:Pt 4

    Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Community-Acquired Infections; Cross Infection; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Virulence; Virulence Factors

2008
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:1

    Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin

2002